{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T06:13:17Z","timestamp":1772863997982,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.mayocp.2025.07.007","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T11:44:57Z","timestamp":1758714297000},"page":"2020-2023","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Inflammatory Bowel Disease in Patients With Type 2 Diabetes Mellitus"],"prefix":"10.1016","volume":"100","author":[{"given":"Shih-Chieh","family":"Shao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel Hsiang-Te","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-Wei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward Chia-Cheng","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10-11","key":"10.1016\/j.mayocp.2025.07.007_bib1","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1007\/s00011-023-01796-y","article-title":"SGLT2 inhibitors prevent LPS-induced M1 macrophage polarization and alleviate inflammatory bowel disease by downregulating NHE1 expression","volume":"72","author":"Kim","year":"2023","journal-title":"Inflamm Res"},{"issue":"11","key":"10.1016\/j.mayocp.2025.07.007_bib2","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2337\/dc19-0162","article-title":"Dipeptidyl peptidase 4 inhibitors and risk of inflammatory bowel disease: real-world evidence in U.S. adults","volume":"42","author":"Wang","year":"2019","journal-title":"Diabetes Care"},{"issue":"1","key":"10.1016\/j.mayocp.2025.07.007_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.50050","article-title":"Sodium-glucose cotransport protein 2 inhibitors in patients with type 2 diabetes and acute kidney disease","volume":"7","author":"Pan","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.mayocp.2025.07.007_bib4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s13098-024-01325-9","article-title":"Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus","volume":"16","author":"Zhang","year":"2024","journal-title":"Diabetol Metab Syndr"},{"issue":"9","key":"10.1016\/j.mayocp.2025.07.007_bib5","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","article-title":"Microbiota and diabetes: an evolving relationship","volume":"63","author":"Tilg","year":"2014","journal-title":"Gut"},{"issue":"5","key":"10.1016\/j.mayocp.2025.07.007_bib6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/EDE.0000000000000504","article-title":"Brief report: negative controls to detect selection bias and measurement bias in epidemiologic studies","volume":"27","author":"Arnold","year":"2016","journal-title":"Epidemiology"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962500391X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002561962500391X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T15:25:37Z","timestamp":1763565937000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002561962500391X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S002561962500391X"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.07.007","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Inflammatory Bowel Disease in Patients With Type 2 Diabetes Mellitus","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2025.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Mayo Foundation for Medical Education and Research. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}